EUVIMEDEUVIMED entdecken
Crossref

B7-H3 promotes angiogenesis in rheumatoid arthritis

Jie Yang, Jian Xiong, Yuling Sun, Li Gu, Yachun Chen, Yundi Guo, Cuiping Liu, Jing Sun

Molecular Immunology · 2024

DOI: 10.1016/j.molimm.2023.12.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Immunology, 2024. Verfasst von Jie Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Biotechnology Suzhou Vocational Health College, Suzhou 215009, China. Hauptthemen laut MEDLINE: Arthritis, Experimental, Arthritis, Rheumatoid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The primary pathological changes of rheumatoid arthritis (RA) include chronic synovial inflammation, bone destruction, and aggressive pannus formation on cartilage, in which angiogenesis plays a critical role. B7-H3, an important immune checkpoint molecule, represents a novel target in tumor therapy and plays a significant role in the pathogenesis of autoimmune diseases. However, its biological mechanism in RA remains unclear. METHODS: Hematoxylin-eosin (HE) staining and immunohistochemistry were used to explore the histological characteristics and expression of B7-H3, CD34, and vascular endothelial growth factor (VEGF) in patients with RA and collagen-induced arthritis (CIA) mice. ELISA was used to detect VEGF, soluble B7-H3, and disease markers in the peripheral blood of patients. A monoclonal anti-B7-H3 antibody was used to treat CIA mice by blocking B7-H3-mediated signaling. RESULTS: The ELISA and HE staining results showed a positive correlation between the expression of B7-H3 and the degree of joint cavity destruction and pannus formation. B7-H3 expression also correlated with increased expression of the vessel biomarkers CD34 and VEGF. Anti-B7-H3 effectively reduced pannus formation in CIA mice. CONCLUSION: B7-H3 modulates angiogenic activity in the joint synovium, demonstrating its therapeutic value in the context of RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, ExperimentalArthritis, RheumatoidAnimalsHumansMiceAngiogenesisAntibodies, MonoclonalInflammationNeovascularization, PathologicSynovial MembraneTranscription FactorsVascular Endothelial Growth Factor AB7 Antigens

Stichwörter der Autor:innen

AngiogenesisB7-H3Rheumatoid arthritis

Substanzen

Antibodies, MonoclonalTranscription FactorsVascular Endothelial Growth Factor ACD276 protein, humanB7 AntigensCd276 protein, mouse

Autor:innen und Institutionen

  • Institute of Medical Biotechnology Suzhou Vocational Health College, Suzhou 215009, China.
  • Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215007, PR China.
  • Institute of Medical Biotechnology Suzhou Vocational Health College, Suzhou 215009, China. Electronic address: jsun@szhct.edu.cn.

Zitieren

APA

Yang, J., Xiong, J., Sun, Y., Gu, L., Chen, Y., Guo, Y., Liu, C., & Sun, J. (2024). B7-H3 promotes angiogenesis in rheumatoid arthritis. Molecular Immunology. https://doi.org/10.1016/j.molimm.2023.12.002

Vancouver

Yang J, Xiong J, Sun Y, Gu L, Chen Y, Guo Y, et al. B7-H3 promotes angiogenesis in rheumatoid arthritis. Molecular Immunology. 2024. doi:10.1016/j.molimm.2023.12.002

BibTeX
@article{Yang2024,
  author = {Yang, Jie and Xiong, Jian and Sun, Yuling and Gu, Li and Chen, Yachun and Guo, Yundi and Liu, Cuiping and Sun, Jing},
  title = {B7-H3 promotes angiogenesis in rheumatoid arthritis},
  journal = {Molecular Immunology},
  year = {2024},
  doi = {10.1016/j.molimm.2023.12.002}
}
Kostenlos starten →